Managing Paraneoplastic Neurological Disorders
- 1 March 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 11 (3), 292-305
- https://doi.org/10.1634/theoncologist.11-3-292
Abstract
Learning Objectives: After completing this course, the reader will be able to: Describe the autoimmune pathogenesis of paraneoplastic neurological syndromes.Explain the clinical value of paraneoplastic antibody detection.Describe the general treatment approach to paraneoplastic neurological syndromes. Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.comKeywords
This publication has 98 references indexed in Scilit:
- Clinical, Magnetic Resonance Imaging, and Electroencephalographic Findings in Paraneoplastic Limbic EncephalitisMayo Clinic Proceedings, 2003
- Inflammatory myopathies: Clinical, diagnostic and therapeutic aspectsMuscle & Nerve, 2003
- Metaiodobenzylguanidine total-body scintigraphy required for revealing occult neuroblastoma in opsoclonus-myoclonus syndromeEuropean Journal of Pediatrics, 2002
- Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisoloneJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Spontaneous neurological improvement in anti-Hu associated encephalomyelitis.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Selective Expression of Purkinje-Cell Antigens in Tumor Tissue from Patients with Paraneoplastic Cerebellar DegenerationNew England Journal of Medicine, 1990
- 3,4-Diaminopyridine in the Treatment of Lambert–Eaton Myasthenic SyndromeNew England Journal of Medicine, 1989
- Opsoclonus, Myoclonus, Ataxia, and Encephalopathy in Adults with CancerMedicine, 1988
- The carcinomatous neuromyopathy of oat cell lung cancerAnnals of Neurology, 1980
- “LIMBIC ENCEPHALITIS” AND ITS ASSOCIATION WITH CARCINOMABrain, 1968